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Abstract
Background: Malaria in pregnancy has important consequences for mother and baby. Coverage with the World Health
Organization–recommended prevention strategy for pregnant women in sub-Saharan Africa of intermittent preventive
treatment in pregnancy (IPTp) and insecticide-treated nets (ITNs) is low. We conducted a systematic review to explore
factors affecting delivery, access, and use of IPTp and ITNs among healthcare providers and women.
Methods and Results: We searched the Malaria in Pregnancy Library and Global Health Database from 1 January 1990 to 23
April 2013, without language restriction. Data extraction was performed by two investigators independently, and data was
appraised for quality and content. Data on barriers and facilitators, and the effect of interventions, were explored using
content analysis and narrative synthesis. We conducted a meta-analysis of determinants of IPTp and ITN uptake using
random effects models, and performed subgroup analysis to evaluate consistency across interventions and study
populations, countries, and enrolment sites. We did not perform a meta-ethnography of qualitative data. Ninety-eight
articles were included, of which 20 were intervention studies. Key barriers to the provision of IPTp and ITNs were unclear
policy and guidance on IPTp; general healthcare system issues, such as stockouts and user fees; health facility issues
stemming from poor organisation, leading to poor quality of care; poor healthcare provider performance, including
confusion over the timing of each IPTp dose; and women’s poor antenatal attendance, affecting IPTp uptake. Key
determinants of IPTp coverage were education, knowledge about malaria/IPTp, socio-economic status, parity, and number
and timing of antenatal clinic visits. Key determinants of ITN coverage were employment status, education, knowledge
about malaria/ITNs, age, and marital status. Predictors showed regional variations.
Conclusions: Delivery of ITNs through antenatal clinics presents fewer problems than delivery of IPTp. Many obstacles to
IPTp delivery are relatively simple barriers that could be resolved in the short term. Other barriers are more entrenched
within the overall healthcare system or socio-economic/cultural contexts, and will require medium- to long-term strategies.
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Introduction
Malaria in pregnancy can have important consequences for the
mother, foetus, and newborn child, yet the harmful effects are
preventable [1]. The adverse outcomes of malaria in pregnancy
can be substantially reduced by interventions that have been
available for over two decades [2–4] and that are inexpensive and
cost-effective [5]. Access to and use of these interventions by
pregnant women is, however, extremely low, representing a failure
of the public health community.
In areas of stable malaria transmission in Africa the World Health
Organization (WHO) recommends a package of intermittent
preventive treatment in pregnancy (IPTp) with sulphadoxine–
pyrimethamine (SP) and use of insecticide-treated nets (ITNs),
together with effective case management of clinical malaria and
anaemia [6]. IPTp consists of two doses of SP taken 1 mo apart
commencing in the second trimester [7,8]. Both IPTp and ITNs are
commonly delivered through antenatal clinics (ANCs) through
collaboration between malaria and reproductive health programmes.
The Roll Back Malaria Partnership aims to ensure that all pregnant
women receive IPTp and at least 80% of people at risk from malaria
in areas of high-intensity transmission use ITNs by 2010 [9], with even
more ambitious targets of 100% for both interventions by 2015 [10].
Achievement of high coverage of these preventive interventions
among pregnant women remains elusive for many countries in
sub-Saharan Africa [11,12]. A recent review of national survey
data shows that in 27 countries with survey data between the years
2009 and 2011, the median coverage of two doses of SP was
24.5% (range 7.3%–69.4%), even though the median coverage for
at least two ANC visits was 84.6% (range 49.7%–96.9%, 22
countries, 2003–2011) (A. M. van Eijk, personal communication),
representing substantial missed opportunities at ANCs. Despite the
call for universal ITN coverage [13] and all 45 malaria-endemic
countries having a policy of providing ITNs to pregnant women,
the median use of an ITN the previous night among pregnant
women in 37 countries from survey data for the years 2009–2011
was 35.3% (range 5.2%–75.5%) (A. M. van Eijk, personal
communication). According to a Countdown to 2015 report, in
20 countries with data, IPTp and ITNs, together with case
management of malaria during pregnancy, have the lowest
coverage among all the interventions delivered to pregnant
women at ANCs [14].
Evidence on the determinants of coverage and reasons for the
failure in delivery and uptake of IPTp and ITNs from qualitative
[15] and quantitative studies is currently disparate, in addition to
which, many relevant reviews are now outdated [5,16–18]. We
therefore undertook a systematic review to update the evidence
and to integrate findings from three separate syntheses of studies
on (1) barriers to achieving high coverage, (2) determinants of
uptake, and (3) interventions to increase coverage. We then
explored the extent to which the intervention studies have
addressed known barriers and determinants, and identified critical
gaps in the knowledge required for the formulation of effective
strategies. The review was restricted to sub-Saharan Africa as the
only malaria-endemic region with a specific WHO strategy for the
prevention of malaria in pregnancy, which includes both IPTp
with SP and ITNs.
Methods
Search Strategy
We performed a systematic and comprehensive literature search
of electronic databases on 23 April 2013, including the Malaria in
Pregnancy Library (http://library.mip-consortium.org; updated
20 April 2013) and the Global Health Database [19], and a search
of bibliographies of retrieved articles. The Malaria in Pregnancy
Library contains peer-reviewed published and unpublished
literature compiled from 40 sources including PubMed, the
Global Health Library, Google Scholar, Lilacs (Latin American
and Caribbean Health Sciences Literature), Popline, the ProQuest
Digital Dissertations and Theses database, Web of Knowledge,
WorldCat, and registers of trials and studies [20]. A full account of
the search terms used is presented in Table S1.
Study Inclusion Criteria and Analysis Strategy
Titles and abstracts were reviewed independently by two
authors (J. Hill and J. Hoyt/A. M. van Eijk). Studies were eligible
for inclusion if they met the following criteria: (1) reported an
original research study; (2) addressed barriers to, facilitators of, or
determinants of the delivery or uptake of IPTp and/or ITNs in
pregnancy, or evaluated the impact of an intervention to increase
the coverage of IPTp and/or ITNs in pregnancy; (3) were
published between 1 January 1990 and 23 April 2013; and (4)
were conducted in sub-Saharan Africa. No restrictions were placed
on publication language or study design, i.e., quantitative,
qualitative, and mixed methods studies were included, and both
peer-reviewed papers and grey literature were included. Studies
meeting the inclusion criteria were grouped according to whether
their content addressed (1) barriers or facilitators, (2) determinants,
and/or (3) evaluation of intervention(s); some studies contributed
to more than one of these content groups (Figure 2). Studies with
content on barriers or facilitators and/or determinants were then
further categorised into studies exploring factors among pregnant
women, healthcare providers, or both. Studies with content on
delivery interventions were categorised by intervention, i.e., IPTp,
ITNs, or both. The kappa statistic was used to measure the
chance-adjusted inter-rater agreement for eligibility.
Data Extraction
Two authors extracted data and appraised the quality and
content of included studies. J. Hill and J. Hoyt/A. M. van Eijk
extracted quantitative and qualitative data on barriers and
facilitators from quantitative, qualitative, and mixed methods
studies using pre-existing themes used by the authors of the
included studies, which were stratified according to whether the
views or perspectives were those of pregnant women or healthcare
providers; the views or perspectives mainly comprised self-reported
information but also observed data. The barrier and facilitator
themes were then divided into four predetermined categories
adapted from the literature [21,22] for pregnant or postpartum
women (Box 1) and for healthcare providers (Box 2). Because
facilitators uniformly reflected the converse of the barriers, we
report only the barriers (Table S4). A. M. van Eijk and J. Hoyt/L.
D’Mello-Guyett extracted quantitative data from quantitative and
mixed methods studies that explored the determinants of receipt of
one or two doses of IPTp and ITN ownership and use, henceforth
referred to as ‘‘determinants’’. J. Hill and J. Hoyt/L. D’Mello-
Guyett extracted quantitative, qualitative, and descriptive data
from the studies evaluating delivery strategies for IPTp and/or
ITNs according to the type of delivery intervention, e.g.,
promotion, training, or type of delivery mechanism.
Two authors (J. Hill and J. Hoyt/L. D’Mello-Guyett) assessed
the quality of reporting of individual studies using a checklist of
criteria developed a priori based on criteria and methods described
in the literature. For observational quantitative studies the criteria
of reporting were randomised sample selection, multivariate
Access to Malaria Prevention in Pregnancy: Africa
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analysis, and minimising bias through study design and analysis
[23,24]. For qualitative studies the criteria were the extent to
which the authors described the sampling strategy, the effects of
reflexivity, and methods to ensure reliability and validity [25,26].
For mixed methods studies, the following reporting criteria were
used: justification of mixed methods, clearly described sampling
strategy, clear reporting of methods for the qualitative component,
analysis strategy, multivariate analyses, minimising bias, and
integration of qualitative and quantitative findings [27,28]. For
intervention studies, reporting criteria were presence/type of
control, steps to reduce bias, and the extent to which authors
described confounding, loss to follow-up, and external validity
[29]. No studies were excluded on the basis of quality.
Data Synthesis
Barriers and facilitators were described and explored using
content analysis and narrative synthesis of qualitative and
quantitative data. Data from the pregnant women’s perspective
were synthesised across four levels (individual, household/social/
cultural, healthcare system, and environmental) and assessed in
relation to receipt of IPTp, ITN ownership, and ITN use.
Similarly, data from the healthcare provider perspective were
synthesised across four levels (individual, organisational, health-
care system and non-healthcare system) and assessed in relation to
the delivery of IPTp and ITNs in the ANC setting.
The intervention studies were grouped into common strategies
and explored using a narrative synthesis to summarise each
intervention and to compare and contrast findings between studies
evaluating similar strategies for scaling up one or both malaria
interventions.
Statistical Analysis
We conducted a meta-analysis of data on determinants using
Stata version 12 (StataCorp) and Comprehensive Meta-Analysis
(Biostat, http://www.meta-analysis.com/). Summary odds ratios
(ORs) were calculated using random effects models based on the
approach of DerSimonian and Laird [30]. Data were extracted
from studies using the following hierarchy based on availability:
Figure 1. Flowchart of studies included in the review.
doi:10.1371/journal.pmed.1001488.g001
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raw data (numerators and denominators); computed unadjusted
ORs, computed adjusted ORs. The use of adjusted (by multivariate
analysis) or cluster-adjusted ORs as provided by the studies is
indicated in the meta-analysis forest plots. If studies presented results
for both ‘‘1+ doses’’ and ‘‘2+ doses’’ of IPTp, only the data for ‘‘2+
doses’’ was used. We conducted sub-group analysis and considered
the following factors for IPTp: number of SP doses (1+ or 2+),
location of enrolment (community or clinic), study population
(postpartumwomen, a mixed population of postpartum and pregnant
women, or pregnant women only), and study country. The subgroup
analysis for ITNs considered location of enrolment (community or
health facility), study population (postpartum women, a mixed
population of postpartum and pregnant women, or pregnant women
only), study country, and—for ITNs—type of net (ITN or untreated
net) and definition of net use (last night or during pregnancy).
Sensitivity analysis was conducted to assess the potential effect of
study quality on the examined associations. We assigned studies a
score based on the quality assessment, and studies that failed to report
on three or more quality criteria scored as low-to-moderate quality.
The I2 and 95% CI were used to quantify heterogeneity [31].
Synthesis across the Barriers, Determinants, and
Intervention Studies
We compared identified barriers with the determinants
identified in the meta-analysis and aligned them with the
intervention studies. The barriers were first collapsed into a
limited number of key categories using a coding template, and the
implications for intervention for each category of barriers were
described. We then matched the proposed interventions derived
from the barrier studies against the intervention studies included in
the review to assess the extent to which the intervention studies
addressed the barriers identified in the observational studies.
Results
Study Selection and Characteristics
The primary search identified 1,780 citations (1,240 from the
Malaria in Pregnancy Library, 540 from the Global Health
Database, and two from bibliographies and authors), from which
271 duplicates were removed (Figure 1). From the remaining
1,511, 1,280 articles were excluded on the basis of abstracts. Of
231 full-text articles reviewed, 133 were excluded as they did not
meet the inclusion criteria, the full text was not available, or they
contained duplicate data, leaving 98 included articles. There was
close agreement between reviewers on the included studies (kappa
score of 0.86).
Of the 98 included studies, 81 contributed data on barriers and
determinants (Table 1), and 20 studies contributed data on
interventions that aimed to increase coverage and uptake of IPTp
(Table 2) or ITNs (Table 3). One study did not contain data in a
usable format for the meta-analysis [32]. The key characteristics of
Figure 2. Analysis strategy. MiP, malaria in pregnancy.
doi:10.1371/journal.pmed.1001488.g002
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the barrier and determinant studies and of the intervention studies
are provided in Table S2.
Of the 48 quantitative studies, the majority of studies were
assessed to be of moderate quality (2–3/5; n=24), with the
remaining studies equally distributed between low (0–1/5; n=13)
and high (5/5; n=11) quality (Table S3). The criterion least
commonly reported among these studies was ‘‘social desirability
minimised’’. The eight qualitative studies were assessed to be of
moderate-to-high quality (4–6/7), with only one study reporting
on saturation and only two studies reporting on reflexivity of the
researcher (Table S3). The majority of the 22 mixed methods
studies were assessed to be of medium (4–6/9; n=11) to high
quality (8–9/10; n=10), with only three studies reporting on use of
multivariate analysis (Table S3). Of the 20 intervention studies, the
majority were assessed to be of moderate quality (2–3/4; n=17),
with four low-quality studies and one high-quality study (4/4)
(Table S3).
Barriers to IPTp Coverage
Barriers to receiving IPTp—the perspective of pregnant
women. For barriers categorised as individual, many of the
barriers to receipt of IPTp reported by women related to their lack
of knowledge about IPTp (see Table S4 for content analysis of
qualitative and quantitative data on barriers). For example,
women were unaware of the benefits of IPTp [33–37] or the
preventive value of SP [38,39], why SP was being given
[35,39,40], and the number of doses, timing, and dose of SP
required [35,36,40–43]. There was also confusion over what drugs
were safe to take during pregnancy [35,36], leading some women
to reject all medication [44] or to fear the perceived side effects of
SP [36,41,45,46], with women in one study fearing that SP would
cause abortions [38]. Women who had had personal experience of
the side effects of SP were also deterred from taking IPTp with SP
[41,43,46–48]. Reasons given for not receiving a second dose of
IPTp included not returning for a second ANC visit [38,49,50]
and illness or shyness [39] or low social position [51] leading to
delayed ANC attendance. This lack of knowledge of IPTp means
that women who take IPTp are placing considerable trust in ANC
staff to provide them with safe and beneficial drugs and services
[37,40,42,44,47].
For barriers categorised as household/social/cultural, it is
common for women to have to purchase SP or water for taking
SP by directly observed therapy (DOT), constituting an important
economic barrier to the uptake of IPTp [35–38,43,52,53].
Commitments to farming, employment, and childcare were
barriers to ANC attendance earlier in pregnancy, resulting in
women receiving no or incomplete doses of IPTp [39,43]. Women
often delayed going to an ANC until the pregnancy was advanced
(about 7 mo gestation) [40] because their husbands did not give
them money for transport [38], presenting a shorter window of
opportunity to receive two doses of IPTp. In Nigeria, women
reported needing their husbands’ support or consent before
attending an ANC or before taking any drugs [36,40].
For barriers categorised as healthcare system–related, women
reported that in some health facilities women who could not pay
the fees were denied services [52], or they were asked to pay
another fee in order to receive the second dose of IPTp [54].
Barriers to receiving SP by DOT were that women had to buy the
drug elsewhere, or that they took it home because they needed to
eat first or because the nurses told them to [55], or that they were
asked to share cups [36]. Among women who did not receive
IPTp, a key reason reported in four studies was that it was not
offered by ANC staff [35,37,46,50,56–58]. They also reported
frequent periodic shortages of SP as a reason for not receiving
IPTp [35,36,43,45,49,50]. Women in Tanzania reported fines and
penalties being imposed by healthcare providers if they started
attending an ANC late in pregnancy [52]. Other reasons for not
receiving SP were that women were taking iron sulphate and folic
acid supplementation [46] or were referred to a laboratory for
testing [46].
Barriers to delivery of IPTp—the perspective of
healthcare providers. Barriers to the delivery of IPTp found
at the individual level centred on the knowledge and perceptions of
healthcare providers about IPTp using SP (see Table S4 for
content analysis of qualitative and quantitative data on barriers).
General knowledge regarding the IPTp strategy among healthcare
providers was considered poor [18,37,39,55,60,61]. Confusion
among healthcare providers over the timing and dosing of SP in
relation to gestational age was commonly cited
[18,33,37,54,55,60,61], in addition to imprecise estimation of
gestational age leading to missed SP doses [62], or SP being given
to women regardless of guidelines for gestational age [37,44,63].
Healthcare providers could not name the major side effects or
contraindications of SP in Ghana or Nigeria [49,53,55,64] and
often gave SP and iron tablets to women without any explanations
or instructions, or instructions were not given in the local language
[44]. Healthcare providers were often found to blame pregnant
women’s behaviour for the poor uptake of IPTp. For example,
healthcare providers in Malawi and Nigeria reported that women
Box 1. Barriers from the Women’s Perspective
by Level
Individual level: factors related to a woman’s knowl-
edge, thoughts, beliefs, actions and behaviour, pregnancy,
and health status
Social/cultural/household level: factors related to a
woman’s economic and social position, household factors
including gender roles, societal and cultural norms and
traditions, and religious practices
Environmental level: factors related to seasonality of
malaria, weather conditions, physical access, and trans-
portation
Healthcare system level: factors related to the various
components and quality of the healthcare system, such as
staff attitudes or performance, medication, service provi-
sion, and user fees
Box 2. Barriers from the Healthcare Provider
Perspective by Level
Individual level: factors related to the knowledge,
attitudes, and performance of individual healthcare pro-
viders
Organisational level: factors related to the operation of
the health facility unit, such as management, staff rosters/
rotation, and services
Healthcare system level: factors that are dependent on
higher levels of the healthcare system related to the
various components and quality of services, such as supply
of drugs or ITNs, development and dissemination of policy
guidelines, training and supervision of staff, and imposi-
tion of user fees
Non-Healthcare system: macro-level factors external to
the healthcare system such as media, water supply, side
effects of medications, and women’s practices
Access to Malaria Prevention in Pregnancy: Africa
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Table 1. Data extracted for barriers and determinants by study.
Study IPTp ITN
Facility-based surveys Barriers Determinants Barriers Determinants
Akaba 2013 [34] ! ! ! !
De Allegri 2013 [82] ! !
Aluko 2012 [71] ! !
Amoran 2012a [35] ! !
Amoran 2012b [72] ! !
Arulogun 2012 [55] !
Bouyou-Akotet 2013 [113] !
Diala 2012 [40] !
Iliyasu 2012 [36] ! !
Mubyazi 2012 [63] !
Mutagonda 2012 [43] !
Namusoke 2012 [59] !
Onoka 2012a [37] ! !
Onoka 2012b [114] !
Onwujekwe 2012 [61] !
d’Almeida 2011 [115] !
Donkor 2011 [48] !
Manirakiza 2011 [116] ! !
Napoleon 2011 [117] ! !
Nduka 2011 [118] !
Okonta 2011 [73] ! !
Olajide 2011 [74] ! !
Tutu 2011 [119] !
Smith Paintain 2011 [64] !
Gross 2011 [33] !
Ambrose 2011 [77] !
Sande 2010 [45] ! !
Antwi 2010 [53] ! !
Mubyazi 2010 [52] ! !
Smith 2010 [47] !
Karunamoorthi 2010 [67] ! !
Wagbatsoma 2010 [120] !
Akinleye 2009 [121] !
Takem 2009 [122] !
Klebi 2009 [123] !
Musa 2009 [69] !
Njoroge 2009 [65] ! !
Adjei 2009 [49] ! !
Mubyazi 2008 [18] !
Pettifor 2008 [76] ! !
Anders 2008 [56] !
Onyeaso 2007 [60] ! !
Mnyika 2006 [124] !
Launiala 2007 [44] !
Brentlinger 2007 [62] ! !
Kweku 2007 [83] !
Van Geertruyden 2005 [78] ! !
Gates Malaria Partnership 2005 [39] !
Mubyazi 2005 [41] !
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did not want to take SP on an empty stomach [37,54], and that
late attendance at the ANC [18,54,61] or women not returning for
subsequent ANC visits [45,61] was a contributor to low IPTp
coverage.
Organisational-level barriers at health facilities were that staff
were sometimes too busy to prescribe SP [54] or that cups
[18,37,41,62] or drinking water was not available to enable
provision of SP by DOT [37,49,63]. An important finding was
that there can be substantial variation across health facilities in the
delivery of IPTp and in the information provided to pregnant
women [18].
Many of the barriers to the effective delivery of IPTp reside
within higher levels of the healthcare system and/or at the policy
level. Guidelines have generally been too complicated, and in
some cases there has been conflicting information from different
programmes within the ministry of health, as occurred in
Tanzania, where two different IPTp guidelines remained in
circulation, one in the 2006 Malaria Diagnosis and Treatment
guidelines and one in the Focussed Antenatal Care guidelines [33].
Several studies identified that guidelines were not available at the
health facilities [33,39,49]. This lack of access to appropriate
information is exacerbated by lack of effective training and
supervision of healthcare providers and lack of quality assurance of
IPTp delivery in facilities [18,37,39,63]. In Tanzania, the change
in national treatment policy from using SP to using artemisinin
combination therapies was poorly managed and led to negative
media coverage about SP and loss in confidence in SP among
healthcare providers and the general public [18]. Related to the
policy context, a pilot IPTp project in Mozambique encountered
multiple incompatibilities between the delivery of IPTp and of
other antenatal care initiatives (e.g., programmes for control of
syphilis, anaemia, and HIV) that had to be overcome [62]. A
Table 1. Cont.
Study IPTp ITN
Nganda 2004 [125] ! ! !
Ashwood-Smith 2002 [54] !
Community-based surveys
Hill 2013 [126] ! !
Ankomah 2012 [80] ! !
Ansah-Ofei 2011 [46] !
Auta 2012 [81] ! !
Zere 2012 [127] ! ! !
Faye 2011 [128] !
O’Meara 2011 [85] !
Ndyomugyenyi 2010 [50] ! !
Grietens 2010 [51] !
Sangare 2010a [57] ! !
Mbonye 2010 [129] !
Sangare 2010b [70] ! !
Beiersmann 2010 [84] !
Acquah 2009 [130] !
Brabin 2009 [42] !
Gies 2009 [90] !
Gikandi 2008 [131] ! !
Marchant 2008 [58] ! !
Belay 2008 [79] ! !
Hassan 2008 [132] !
Kiwuwa 2008 [133] ! !
Ouma 2007 [91] !
PSI Burundi 2006 [134] !
PSI Rwanda 2006 [135] !
PSI Zambia 2006 [136] !
Mbonye 2006a [38] !
Mbonye 2006b [66] !
van Eijk 2005 [68] ! ! !
Guyatt 2004 [137] ! ! !
Marchant 2002 [75] ! !
Summary total 38 31 28 27
doi:10.1371/journal.pmed.1001488.t001
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major barrier identified in several studies was periodic stockouts of
SP, sometimes for extended periods [18,37,44,49,53,54,62,63].
This results in women either being turned away without being
given IPTp or being given a prescription to go and buy the drug
from a private drug seller [38] or from a pharmacy at another
government facility, and represents a serious missed opportunity,
as there is no guarantee that the women will buy and take the
drug. Practices in private facilities often differ from those in
government health facilities: private facilities are more likely to fail
to adhere to national guidelines on IPTp delivery, to charge user
fees for IPTp [18], or to dispense other malaria drugs requested by
pregnant women [41], creating inconsistencies within national
programmes. Delivery of IPTp is impeded by a lack of basic
facilities, drug shortages, and insufficient training or support and
remuneration [63], with either staff being too busy [54] or SP not
being available, such that user fees are levied for IPTp even where
it is supposed to be provided free [37,63].
Barriers to ITN coverage
Barriers to ITN uptake and use—the perspective of
pregnant women. A common individual-level barrier to use
of ITNs was associated with the inconvenience and discomfort of
using an ITN (see Table S4 for content analysis of qualitative and
quantitative data on barriers). Pregnant women described feeling
hot and uncomfortable under the net while sleeping [34,48,65–74]
and the inconvenience of putting it up and taking it down each
night [67,68,72–74]. The belief that the chemicals used to treat the
ITNs were harmful to pregnant women and their unborn child
was reported as a barrier in studies in Nigeria [74], Ghana [48],
Kenya, and Uganda, which led to many women discontinuing use
of ITNs [65,66]. In Nigeria, women did not believe that ITNs
prevented malaria [34,73].
At the household/social/cultural level, the most frequently
reported barrier to ITN access for pregnant women was cost
[65,66,69,71–78]. The studies describing cost as a major barrier
were undertaken in countries in east, west, and central Africa and
involved both rural and urban populations, suggesting cost is a
common barrier to ITN access in many contexts. Women in
several studies indicated either a lack of support from their
husband [34,66,79] or that they were reliant on their husband to
purchase the ITN on their behalf [70,75]. A barrier to adolescents
and primigravidae using ITNs was the perception among
community members and the pregnant women themselves that
these groups were at a low risk of getting malaria [66]. Place of
residence [48,71,79–82,99], seasonality of use (low in hot weather)
[65,67], and perceptions that there were no mosquitoes in the area
[68,77,79] were the main environmental barriers.
The main barrier at the healthcare system level cited by
pregnant women was the ‘‘unavailability’’ of ITNs
[66,69,71,74,79]. These stockouts can exacerbate the issue of cost
in many cases, as women often travel to distribution points to
collect the ITN, incurring both direct and indirect costs, only to
find the ITNs out of stock [52]. Barriers associated with the
distribution of ITN vouchers through ANC services in Tanzania
included long travel distances to redeem the vouchers, variation in
top-up costs, and the negative attitudes of ANC staff when women
return without having redeemed their voucher [52]. Once women
obtain an ITN, they do not always use them. The side effects
(burning eyes), heat, and restrained mobility were seen to prevent
women from using ITNs, according to healthcare providers in
Ghana [48].
Barriers to delivery of ITNs—the perspective of
healthcare providers. Healthcare providers frequently identi-
fied insufficient stock to meet the demand as a major barrier
[83,84] (see Table S4 for content analysis of qualitative and
quantitative data on barriers). A study in Kenya found that despite
pregnant women being eligible for a free ITN at ANC services,
households with a pregnant woman who recently attended ANC
services were no more likely to own an ITN than households
without a pregnant woman [85], suggesting that free distribution
programmes are not always effective at reaching their target
population. While the delivery of ITNs or vouchers through ANC
services provide extra incentive for pregnant women to attend
ANC services [52,84], it was noted that some women do not
return to the ANC once they have received their free ITN [84].
Determinants of IPTp and ITN Uptake and Use among
Women: Meta-Analysis
The key determinants of IPTp receipt among women from 31
studies were number and timing of ANC visits, parity/gravidity,
education, knowledge about malaria/IPTp, socio-economic status,
and use of ITNs (Figure 3; Text S2). Receipt of IPTp was higher
among women making 3–4 ANC visits compared to women
making fewer visits and among women first attending an ANC in
their first or second trimester compared to those registering in
their third trimester. Primigravidae were more likely to receive
IPTp than multigravidae, with significant variation among studies
(I2 90%, 95% CI 86–94; Text S2). More highly educated women
were more likely to receive IPTp than women with less or no
education, as were wealthier women. There was no association
between IPTp receipt and location of residence; however, there
was high heterogeneity between studies (I2 94%, 95% CI 91–96)
and significant variation by country (p,0.001; Text S2). ITN users
were also more likely to have received IPTp, as were women with
greater knowledge of malaria. Sensitivity analysis suggested that
the association between IPTp uptake and being primigravid, and
between IPTp uptake and higher number of ANC visits, was
stronger in the studies that were scored low-to-moderate quality
than in the better quality studies (Text S2).
The key determinants of ITN use among pregnant women from
27 studies were age, marital status, education, knowledge about
malaria/ITNs, employment status, and receipt of IPTp (Figure 4;
Text S2). Older women (aged .19 y) and married women were
the most likely to use an ITN. Women with higher education or
greater knowledge of malaria or ITNs were more likely to use
ITNs than women with lower education or less knowledge, and
women who were employed in a wage-paying job were also more
likely to use ITNs during pregnancy than farmers or housewives.
Women who had received IPTp were more likely to use ITNs.
The effect of education on ITN use showed significant variation by
country (p=0.028; Text S2), and the effect of marital status on
ITN use varied significantly by location of enrolment (p=0.001;
Text S2). Sensitivity analysis indicated a stronger association
between ITN use and marital status in the low-to-moderate quality
studies compared to the better quality studies (Text S2).
Intervention Studies
Interventions to increase coverage of IPTp. The evidence
from four studies that evaluated community-based distribution of
IPTp suggests that community resources have the potential to
complement the delivery of IPTp through ANCs to increase access
to and uptake of IPTp among pregnant women [86–89] (Table 2).
However, there was evidence that community-based distribution
may concurrently reduce women’s attendance at ANCs, though
this was not consistent across the four studies: two studies showed
reduced ANC attendance in the intervention sites [86,87], and two
showed increased ANC attendance [88,89]. An alternative to
delivering IPTp through community-based programmes is to
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employ community-based resource persons to promote IPTp,
while referring women to ANCs to be given SP. This approach
had substantial success in Burkina Faso, and resulted not only in
higher IPTp coverage (71.8% versus 49.2% in intervention and
control groups, respectively; p,0.001) but also in women
attending the ANC earlier, in their first or second trimester
(81.3% versus 70.4% in intervention and control groups,
respectively; p,0.001), and in more women making two or more
visits (89.3% versus 75.3% in intervention and control groups,
respectively; p,0.001) [90].
One intervention study evaluated strategies to improve
healthcare provider knowledge and performance on how to
deliver IPTp. The study was undertaken in Kenya, 4 y after the
national IPTp policy was adopted, and suggests that retraining of
healthcare providers on the delivery, timing, and dosing of IPTp
significantly increased coverage of IPTp (36.9% versus 10.9% in
intervention and control groups, respectively; p,0.001) [91].
Interventions to increase coverage of ITNs. The included
intervention studies evaluated two main channels for delivering
ITNs to pregnant women: campaign delivery (non-targeted)
[89,92–94] and routine delivery to pregnant women through
ANC services (targeted), with three alternative mechanisms
evaluated at ANCs: distribution of free nets with [95–97] or
without social marketing [98,99], and distribution of subsidised
vouchers [83,84,100–102]. One study compared the impact of
ANC delivery alone versus ANC delivery plus community-based
distribution of subsidised nets in Niger (Table 3).
Campaign delivery of ITNs to households with pregnant
women [89], households with children under 5 y [94], or poor
households [93] had limited impact on increasing coverage among
pregnant women with one exception, which was a campaign in
Senegal that delivered ITN vouchers to all households with
children under 5 y, alongside vitamin A and mebendazole (an
anthelmintic) [92] (49.2% versus 28.5% ITN coverage in
intervention versus control groups, respectively; no statistical
analysis reported). In a comparison study in Tanzania, the
Tanzania National Voucher Scheme, which provides a voucher
subsidy to pregnant women at ANCs, which is then used to
purchase an ITN from a contracted retailer, achieved greater
coverage than a 3-d mass campaign targeting ITNs to households
with infants, based on the assumption that infants sleep with their
mothers, a common practice in this setting, or ITNs sourced from
retailers [94]. The voucher scheme was, however, inequitable,
with fewer poorer women receiving nets [100]. In a comparison
Figure 3. Summary odds ratios of determinants of IPTp receipt assessed in 19 studies with quantitative data. All studies used 2+ doses
of SP versus less except four studies, which used 1+ doses of SP versus less; these are Mbonye 2010 [129], van Eijk 2005 [68], Nganda 2004 [125], and
Napoleon 2011 [117]. SES, socio-economic status.
doi:10.1371/journal.pmed.1001488.g003
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study of routine ANC delivery of ITNs alone and ANC delivery
plus community-based distribution, there was no significant
difference in ITN use among pregnant women between groups
[103]. Routine delivery of ITNs through ANCs, by comparison,
appeared to be more successful in reaching pregnant women, with
four studies demonstrating an increase in ITN coverage among
pregnant women compared to baseline [98,99,101,102]. Pro-
grammes that delivered vouchers, as opposed to free nets, to
women at ANCs experienced more operational challenges [83],
and were dependent on retailers having ITN stock available [84].
Social marketing campaigns have been effective in promoting
the use of ITNs in some settings through extensive media and
educational campaigns that increase awareness about the benefits
and importance of ITN use (especially for pregnant women),
coupled with provision of readily available ITNs at low cost. They
are, however, comparatively expensive to implement and sustain
[104].
Implications for Interventions to Address Barriers
We aligned the barriers to uptake of IPTp and ITNs against the
findings from the intervention studies to determine the extent to
which these interventions addressed known barriers (Tables 4 and
5). There were four key categories of barriers to women receiving
IPTp: pregnant women’s knowledge of IPTp, access to an ANC,
affordability of ANC services, and quality of ANC services.
Women’s lack of knowledge of IPTp was very common and yet
may be improved through relatively simple promotional activities
delivered through all available channels, such as community-based
resource persons, facility-based counselling and education, and
messaging via the media and local leaders. We identified only one
relevant intervention study, which evaluated community-based
promotion of IPTp in Burkina Faso [90]. Women’s access to an
ANC was a barrier in remote settings, where community-based
distribution or outreach services may be required to supplement
ANC services. Four studies evaluating community-based distribu-
tion of IPTp were identified in the review, using a combination of
existing [87,88] or new community resource persons [86,89].
Six key categories of barriers to healthcare providers delivering
IPTp were identified: provider knowledge of IPTp, provider
attitudes, health facility organisation, policy and guidance, fees for
services, and supply of SP. Poor knowledge and poor administra-
tion of IPTp guidelines by healthcare providers appear to be
substantial barriers to achieving high coverage, as highlighted in
several studies included in this review. Provider knowledge of the
IPTp strategy could be improved through retraining and closer
supervision by district staff; however, only one study was identified
that evaluated the impact of retraining of healthcare providers in
Kenya on the delivery, timing, and dosing of IPTp [91]. Simplified
Figure 4. Summary odds ratios of determinants of ITN use assessed in 17 studies with quantitative data. SES, Socio-economic status.
doi:10.1371/journal.pmed.1001488.g004
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policy and guidance on IPTp would be a relatively simple
intervention to improve healthcare provider practice in delivering
IPTp, and while no relevant intervention study was identified, one
study in Tanzania modelled the effect of simplified guidelines on
coverage with IPTp, demonstrating that coverage could be
increased with simplified guidance [33]. No intervention studies
were identified that addressed supply of SP, even though this was
one of the commonest barriers identified in the observational
studies. Poor healthcare provider attitude is a generic problem
often entrenched in resource-constrained healthcare system and
public sector settings, and may be difficult to address; no relevant
intervention studies were identified. Similarly, user fees at ANCs
are a generic barrier to ANC services, and no intervention studies
were identified that addressed this.
Three key categories of barriers to women receiving and using
ITNs were identified: pregnant women’s knowledge of ITNs,
household or cultural constraints, and access to ITNs. As for IPTp,
pregnant women’s knowledge of ITNs as well as certain household
and cultural constraints could be addressed through promotion of
ITNs through a variety of channels. Social marketing using
extensive media and educational campaigns has been used in a
large number of countries, and three evaluation studies were
identified in this review [95–97]. Access to ITNs has been a
problem for women in terms of direct and indirect costs, ITN
availability, and access to distribution points. Three studies
evaluated the delivery of free ITNs to pregnant women through
ANCs [98,99] or campaigns [92], one study evaluated commu-
nity-based delivery of subsidised ITNs [103], and seven studies
evaluated voucher subsidies delivered through ANCs [83,84,100–
102] or campaigns [93,94]. Categories of barriers to healthcare
providers delivering ITNs were similar to those for the delivery of
IPTp: provider knowledge, provider attitudes, health facility
organisation, fees for services, and supply of ITNs. We did not
find any relevant studies that evaluated interventions that directly
addressed these provider barriers.
Discussion
To our knowledge this is the first systematic review of the factors
affecting the delivery, access, and use of interventions to prevent
malaria in pregnant women that uses research findings from
quantitative, qualitative, and mixed methods studies, that assesses
both user and provider perspectives, and that integrates these
findings with intervention studies. This analysis provides a
comprehensive basis for identifying key bottlenecks in the delivery
and uptake of IPTp and ITNs among pregnant women, and for
understanding which scale-up interventions have been effective, in
order to prioritise which interventions are most likely to have the
greatest impact in the short or medium term.
Barriers to the delivery of IPTp and ITNs were found at
different levels of implementation, and broadly fall into policy and
guidance, healthcare system issues, health facility issues, and
healthcare provider performance. Whilst many of the barriers
reflected broader weaknesses in the healthcare system, some were
specific to the intervention. With regard to IPTp, a key identified
barrier to effective delivery was healthcare provider confusion
about the timing of the two doses of IPTp and whether IPTp can
be given on an empty stomach. This confusion stemmed from a
combination of unclear policy and guidance, inadequate training,
and lack of information and job aids on IPTp. Several studies
reported conflicting national policies with regards to provision of
IPTp in relation to management of HIV and other diseases or
conditions, and when to give IPTp if women have been treated for
malaria, a problem also identified in another review [105]. Also,
some studies reported that healthcare providers expressed
uncertainty over the effectiveness of SP for IPTp. Clearly there
is an urgent need for countries to update national IPTp policy and
guidance, and to ensure that this information reaches frontline
providers at ANCs and outpatient departments providing treat-
ment to pregnant women for illness, e.g., through directives or
memos from the Director of Medical Services, as done in Kenya
(M. J. Hamel, personal communication). The recent WHO IPTp
policy update recommendation with simplified guidance on IPTp
dosing, which also restates the continued effectiveness of IPTp
with SP, serves as an important opportunity for national
programmes to update and reinvigorate their IPTp strategy [106].
Organisational problems at the facility level were also common,
such as lack of privacy and confidentiality in the health encounter
[51] and the restriction of hours of ANC services, resulting in high
client-to-staff ratios, long waiting times [49,52], and reduced
consultation times, all of which contribute to poor quality of care
at ANCs. Absenteeism and high staff rotation at the facility leading
to lack of continuity of care and high workload among staff on
duty was also reported [62]. Most of these organisational problems
present another area for improvement in the short term that does
not require additional resources, though it will require better
management and accountability by the heads of health facilities.
Other barriers were, however, dependent on higher levels of the
healthcare system, such as high staff turnover [62], understaffing
(particularly in remote areas), poor infrastructure [41], poor
supervision, and poor use of data to identify problems and inform
decision-making. These problems are inherent in the healthcare
systems in some areas in some countries, and will require longer
term strategies and increased investment in healthcare system
strengthening. Also persistently reported across the studies and
dependent on action taken at higher levels were stockouts of both
SP for IPTp and ITNs, and lack of water or cups for providing
IPTp by DOT. The reviewed studies did not explore the reasons
for the stockouts, but they are likely to be a combination of lack of
funding at the national level for procurement of commodities (i.e.,
specific to IPTp and ITNs) and problems in supply chain
management.
Barrier studies among women highlighted additional healthcare
system barriers leading to poor uptake of IPTp and/or ITNs.
Having to pay user fees or pay for SP, drinking water for DOT, or
ITNs was a common barrier, as were the indirect costs associated
with visiting ANCs, such as transport, food, and opportunity costs.
This finding was supported by the meta-analysis of determinants of
coverage among pregnant women, which showed that socio-
economic status and employment status are important predictors
of IPTp and ITN coverage, respectively. These inequities may to
some extent reflect the determinants of women’s access to ANCs,
where user fees are routinely applied to registration, consultations,
laboratory tests, and drugs, as identified in a review of factors
affecting utilisation of antenatal care in developing countries [107].
However, in some instances user fees are also applied to SP (e.g.,
where women have to purchase SP or water to take IPTp by
DOT) and to ITNs [108]. This situation calls for a review of
charging policies for IPTp and ITNs across national programmes,
and of user fees and charges at ANCs in general. Another common
barrier to ANC utilisation was the poor quality of interactions
between healthcare providers and pregnant women [38,41].
Women were generally perceived as passive recipients and were
provided with little or no information about the services provided
[44], and women with a low social position, such as adolescents
[51], and less educated women are most vulnerable. This issue
appears to be a problem in some resource-poor settings and is
more difficult to tackle. However, educating women about their
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Table 4. Synthesis matrix comparing findings from observational studies with those of intervention studies for IPTp.
Type of Factor Findings from Observational Studies Findings from Intervention Studies
Categories Derived from Barriers
Implications for
Interventions to
Increase Uptake
Type of Intervention
Evaluated
Number of Intervention
Studies
Pregnant
women factors
Category 1—pregnant women’s knowledge
Example barriers
N Lack of knowledge of the preventive
benefits of IPTp
N Belief that use of drugs or SP in pregnancy
is unsafe, e.g., could cause abortion
N Fear of perceived side effects of SP
N Unaware of the dangers of malaria in
pregnancy
Promotion of IPTp
strategy and safety of SP
for IPTp through a variety
of channels, e.g., community-
based, clinic-based, media,
local leaders
Community-based promotion
of IPTp and referral of
women to ANC
1 study in Burkina Faso (Gies
2009 [90])
Category 2—access to ANC
Example barriers
N Poor access to ANC
N Direct and indirect costs of accessing ANC
N Commitments to farming, employment, or
childcare
N Unwillingness to reveal pregnancy
N Lack of awareness of importance of ANC
services
Community-based
distribution of IPTp in
hard-to-reach populations
with limited access to ANC,
e.g., through community-
based volunteers and/or
community-based referral
systems to increase use of
ANC
Community-based
distribution in settings with
poor access to ANC, or
community-based
distribution in settings with
existing drug distribution
programmes, e.g.,
onchocerciasis, or
community-based referral of
women to ANC
3 studies evaluating community-
based distribution of IPTp
(Okeibunor 2011 [89],
Msyamboza 2009 [86], Mbonye
2007 [87]); 1 study in Uganda
(Ndyomugyenyi 2009 [88]); 1
study in Burkina Faso (Gies 2009
[90])
Category 3 –affordability of ANC services
Example barriers
N ANC registration fees
N Laboratory fees
N Cost of SP
N Unofficial penalties charged by healthcare
providers for late ANC attendance
See healthcare provider
factors
Category 4—quality of ANC services
Example barriers
N Providers do not offer IPTp
N SP unavailable
N Lack of water or cups for DOT
N Poor attitudes of healthcare providers
N Lack of information or instructions given by
healthcare providers regarding IPTp
See healthcare provider
factors
Healthcare
provider factors
Category 1—provider knowledge
Example barriers
N Poor knowledge of IPT strategy, timing and
dosage of SP
N Imprecise estimation of gestational age
N Confusion about when to give IPTp in relation
to treatment of malaria, HIV, or other
N Perception that women will or should not take
SP on empty stomach
Training and supervision of
healthcare providers
Training of healthcare
providers
1 study in Kenya (Ouma 2007
[91])
Category 2—provider attitudes
Example barriers
N Health education not given in local
language
N Information and instructions on IPTp not
given to pregnant women
N Providers do not offer IPTp
N Providers treat women with lack of respect
Training and supervision of
healthcare providers on
provider–client interactions
None None
Category 3—health facility organisation
Example barriers
N Restrictive ANC hours
N Lack of cups or drinking water
N Frequent provider absence from work
N Ineffective staff rosters
Reorganisation of staff
rosters, opening hours, etc.,
and better management,
supervision, and
accountability of staff
None None
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rights and about the ANC services available to them may go some
way to empowering women to be able to demand better services.
This finding is supported by the fact that pregnant women’s
lack of knowledge and understanding of IPTp and ITNs was
consistently reported in both the barrier and determinant data as
an important factor preventing the uptake and use of IPTp and
ITNs. Women who understand the benefits of IPTp and the
safety of SP, and how and when to take it, are more likely to take
it. However, many women do not receive adequate information
about IPTp, and this can result in fears that the drug causes
harm, even abortion [15], or women showing preference for an
alternative drug. Whilst there are some reports that women
experience side effects from IPTp, the severity and extent of these
events are not clearly described. There were also reports of
women fearing that the chemical used on ITNs would harm the
foetus [15]. Whilst knowledge is also an important facilitator of
ITN use, barrier studies reveal important deterrents to ITN use
such as the inconvenience and discomfort of use [109], especially
in the dry season, and the lack of a culture or habit of net use.
These findings were consistent with the meta-analysis of
determinants in that coverage of both IPTp and ITNs was lower
among women with no education and, in some countries, women
living in rural areas; these women were less likely to access ANC
and/or health education services. The meta-analysis was useful in
identifying other important risk groups. Younger or adolescent
women, unmarried women, and less educated women were
significantly less likely to use ITNs. The barrier studies show that
this may be related to lower affordability and in-household access
among these women. Adolescents, unmarried women, and less
educated women therefore constitute high-risk groups for
targeting ITNs. This suggests that ministries of health need to
pay more attention to IPTp and ITN promotion and health
education, with additional targeting of risk groups, as well as
using new innovations for communication of messages, since
traditional health education is not offered at all facilities or is not
always effective.
Women seeking care at ANCs often have to overcome barriers
at the household or societal level, and these barriers are more
challenging to address. Women have commitments to farming or
employers and the responsibility of childcare, and often have to
defer to their husbands or in-laws in decision-making over
accessing ITNs or use of household income to pay for ANC
services. In a review of ANC access, use of ANCs was shown to
increase with husband’s educational level and was an even
stronger predictor than women’s education in some settings [107].
Local cultural norms and practices present a considerable barrier
to women accessing ANC services in some but not all study
countries, with wide variation within countries and between
countries, a finding also reported in the review by Pell et al. [15].
In comparison to the observational studies, the review identified
comparatively few studies that evaluated interventions to promote
scale-up of these interventions, particularly for IPTp. Whilst many
of the barriers to IPTp and ITN coverage identified in the
observational studies related to healthcare providers and service
delivery, very few studies that evaluated interventions to improve
service delivery were found. Similarly, very few studies explored
the determinants of delivery of either IPTp or ITNs among
healthcare providers, or supply-side interventions designed to
improve the quality of delivery of IPTp or of ITNs with a chosen
strategy, whether it be campaigns or routine delivery through
ANCs. Of the six studies that evaluated interventions to increase
coverage of IPTp, all but one targeted women’s knowledge or
access, the last being a healthcare provider intervention. Consid-
eration of the context for employing community-based distribution
of IPTp is important; this distribution strategy appears to be an
effective additional strategy to boost coverage in areas where there
is already a successful community-based distribution programme,
as seen in the onchocerciasis control programme in Uganda [88],
Table 4. Cont.
Type of Factor Findings from Observational Studies Findings from Intervention Studies
Categories Derived from Barriers
Implications for
Interventions to
Increase Uptake
Type of Intervention
Evaluated
Number of Intervention
Studies
Category 4—inadequate guidance on IPTp
Example barriers
N Variation in information given to healthcare
providers on IPTp
N No guidelines available at facility
N Lack of supervision and monitoring of IPTp
N Lack of recent training on IPTp
N Private facilities following different practices
N Incompatibilities between delivery of IPTp and
other health interventions
Provision of consistent,
simple guidelines to all
health facilities, both
public and private sectors,
together with training and
supervision
Modelling the effect of
simple guidelines on
coverage with IPTp
1 study in Tanzania (Gross 2011
[33])
Category 5—fees for ANC services
Example barriers
N ANC registration fees
N Cost of SP
N Unofficial penalties charged by healthcare
providers for late ANC attendance
Modification or removal of
user fees and regulation
against imposition of
penalties
None None
Category 6—supply of SP
Example barriers
N SP unavailable
N Poor stock control
Timely procurement and
distribution systems for SP,
and system to prioritise use of
funds for SP at health facilities
None None
doi:10.1371/journal.pmed.1001488.t004
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Table 5. Synthesis matrix comparing findings from observational studies with those of intervention studies for ITNs.
Type of Factor Findings from Observational Studies Findings from Intervention Studies
Categories Derived from Barriers
Implications for
Interventions to Increase
Uptake
Type of Intervention
Evaluated
Number of Intervention
Studies
Pregnant women
factors
Category 1—pregnant women’s
knowledge
Example barriers
N Lack of knowledge of benefits of ITNs
for mother and child
N Discomfort of using ITNs
N Lack of habit of using ITNs
N Fear of chemicals used on ITNs
N Perception that there are no mosquitoes
Promotion of ITN strategy and
safety of insecticides used to
treat nets through a variety of
channels, e.g., community-
based, clinic-based, media, local
leaders
Promotional campaigns
using a variety of
channels, e.g., social
marketing, clinic-based,
media
3 social marketing studies by
PSI in Burundi (2007 [97]),
Kenya (2008 [95]), and
Madagascar (2009 [96])
Category 2—household or cultural
constraints
Example barriers
N Lack of support from husband and/or
community
N Lack of cultural habit of using ITNs
N Cultural beliefs, e.g., resemblance of
ITNs to burial shrouds
Promotion of ITN strategy and
safety of insecticides used to
treat nets through a variety of
channels, e.g., community-based,
clinic-based, media, local leaders
As above As above
Category 3—access to ITNs
Example barriers
N Lack of retailers
N Cost of ITNs
N Inability to pay top-up fees on vouchers
N Direct and indirect costs of accessing ITN
distribution points
Delivery of free ITNs to
pregnant women through
ANC or campaigns, or delivery
of voucher subsidies through
ANC or campaigns, or
community-based distribution
of subsidised ITNs
Delivery of free ITNs to
pregnant women
through ANC or
campaigns, or delivery
of voucher subsidies
through ANC or
campaigns, or
community-based
distribution of subsidised
ITNs
3 studies evaluated free ITNs:
2 studies through ANC
(Pettifor 2009 [98], Guyatt
2003 [99]) and 1 study
through campaign delivery
(Thwing 2011 [92]); 7 studies
evaluated voucher subsidies:
2 studies via campaign
delivery (Ahmed 2010 [93],
Khatib 2008 [94]), 5 studies
via ANC (Beiersmann 2010
[84], Marchant 2010 [100],
Hanson 2009 [101], Muller
2008 [102], Kweku 2007 [83]);
1 study community-based:
Nonaka 2012 [103]
Healthcare provider
factors
Category 1—provider knowledge
Example barrier
N Lack of knowledge of ITN benefits for
mother and child
Training and supervision of
healthcare providers on ITNs
None None
Category 2—provider attitudes
Example barriers
N Providers refuse to offer ITNs to
pregnant women
N Providers impose eligibility criteria for
ITNs or vouchers
Better training, management,
supervision, and accountability
of staff
None None
Category 3—health facility organisation
Example barriers
N Vouchers not available at facility
N As for IPTp
Reorganisation of staff rosters,
hours, etc., and better
management, supervision, and
accountability of staff
None None
Category 4—fees for ANC services
Example barriers
N ANC registration fees
N Cost of ITNs
Removal of user fees and
regulation against imposition
of penalties
None None
Category 5—supply of ITNs/vouchers
Example barriers
N Poor stock control
N Stockouts of ITNs
N Vouchers not available
Timely procurement and
distribution systems for ITNs
or vouchers
None None
doi:10.1371/journal.pmed.1001488.t005
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but may serve to undermine women’s attendance at ANCs in areas
where ANC attendance is fragile. Community-based promotion, on
the other hand, has the potential benefit in some settings of
increasing access and uptake of IPTp by providing women with
information about the importance and benefits of IPTp, and at the
same time reinforcing the message that women should obtain
antenatal care from ANCs, where they benefit from the full range of
focussed ANC services [90]. While 13 studies were identified that
evaluated the effectiveness of alternative delivery strategies to
increase ITN coverage among pregnant women, the study
objectives and designs were heterogeneous; hence, it was not
possible to draw generalisable conclusions. Nevertheless, ANC
services appear to be an important source of free ITNs for pregnant
women in rural areas, a finding supported in a review of best
practices of ITN programmes in sub-Saharan eastern Africa [108].
Strengths and Limitations of the Review
The review triangulates data from quantitative, qualitative,
and mixed methods studies to increase the content validity and
comprehensiveness of the review; it does not, however, attempt
a full meta-ethnography of qualitative data, which has been
undertaken recently by others [15,110]. The meta-analysis of
determinants was used to explore the range of effects between
studies and to provide a pooled analysis to support the findings
of the narrative (interpretive) synthesis. Although the use of
cluster-unadjusted ORs may have overestimated precision, these
were limited to four out of 36 studies. There was considerable
heterogeneity among studies included in the meta-analysis, and
we explored only a limited number of variables in the subgroup
analysis to assess whether these could explain the differences
between studies (Text S2). The lack of adjustment for ANC
attendance in studies using community-based surveys means that
the determinants of IPTp use may be partly driven by
determinants of ANC access. However, the differences in the
results between studies that enrolled women in the community
and those that enrolled women in clinics in the subgroup
analysis were not significant (Text S2). Whilst distinguishing
between use of SP for treatment versus use for prevention poses
an important challenge in interpreting community surveys, this
limitation was not measured in the studies included in the meta-
analysis. Whilst no restrictions were placed on the language of
publication, and no studies were excluded on the basis of
language, the focus the Malaria in Pregnancy Library (the
primary source of studies) to date has been on the European
family of languages and predominantly English. Reviewer bias
was limited by the use of two independent reviewers to assess
inclusion criteria. Reporting of included studies was assessed for
quality, and reporting quality for the majority of studies was
assessed to be fair. There were three quantitative studies that
met no reporting quality criteria and 13 studies that met only
one criterion (10 quantitative and three intervention studies).
Findings from the studies with data on barriers were found to be
entirely consistent with findings from other studies, and provided
no new or surprising themes, and inclusion of these studies did
not alter the study findings.
Our review includes 98 studies from across sub-Saharan Africa,
with 77 of these specifically containing data on barriers and
determinants of delivery, access, and use of IPTp and ITNs among
healthcare providers and pregnant women; this is a sizeable body
of evidence. In summary, the delivery and uptake of IPTp and
ITNs by pregnant women is impeded by a wide range of factors
among both pregnant women and the healthcare system, each
influenced by an array of social, cultural, economic, and
institutional factors, with each factor influenced by the others in
a complex interchange. There are also geographic variations, with
some barriers more prominent in some countries than in others.
Notwithstanding this complexity, many of the barriers highlighted
in this review are relatively consistent across countries and are
surmountable: barriers that programmes can address in the near
term with limited additional investment. Delivery of ITNs through
ANCs presents a narrower range of problems than delivery of
IPTp. Actions to increase coverage of IPTp and ITNs in the short
term would be (1) to simplify country policies and guidance to
align the updated WHO IPTp policy [106] with the new WHO
policy for focused antenatal care, consisting of four visits in the
second and third trimesters, and ensure effective dissemination to
frontline healthcare providers through training and job aids; (2) to
earmark funding for procurement of SP and ITNs; (3) to review
ANC fee structures; and (4) to launch targeted promotional
campaigns to reach high-risk populations of pregnant women,
according to local settings, e.g., rural, poor, or adolescent women.
Promotional campaigns will need to reflect the needs of women
and offer services they will accept at a price they can afford.
Other barriers are more entrenched within the overall healthcare
system and will require medium- to long-term strategies to improve
the overall quality of antenatal services and encourage the habit of
ANC use among women. New multifaceted interventions should be
explored, such as quality improvement initiatives that link improve-
ments in delivery of IPTp and ITNs to other core ANC services,
management tools for facility-level decision-making, and innovations,
such as use of mobile phones for defaulter tracing, supply chain/stock
control, reporting of health management information systems data on
coverage, and surveillance. Increasing drug resistance means that
IPTp with SP will most likely be replaced by more complicated and
expensive drug regimens [4,111], or new strategies, such as
intermittent screening and treatment [112]. Intermittent screening
and treatment will require adjustments to bemade in the ANC setting
[47,64], and will not have the added benefit of IPTp in controlling
infections that cannot be detected by rapid diagnostic tests or
microscopy. Malaria prevention estimates have increased only
modestly between 2007 and 2010 (from 13.6% to 21.5% coverage
for IPTp and from 17.0% to 38.8% coverage for ITN use) [138].
Conclusion
Our synthesis shows that the key barriers to access, delivery, and
use of IPTp and ITNs are relatively consistent across countries.
These barriers may be helpful as a checklist for use by country
malaria programmes and/or policy-makers to identify factors
influencing uptake of these interventions in their specific location
or context. The review also highlights the need for multi-country
studies that evaluate targeted or multifaceted interventions aimed
to improve the delivery and uptake of IPTp and ITNs. More
research is also needed to understand and improve the policy
change process to facilitate future replacement of SP with
alternative drug regimens for IPTp or alternative strategies such
as screening and treatment that will present even greater
challenges for delivery.
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Editors’ Summary
Background. Half the world’s population is at risk of
malaria, a mosquito-borne parasite that kills a million people
every year. Most of these deaths occur among young
children in sub-Saharan Africa, but pregnant women and
their unborn babies are also vulnerable to malaria. Infection
with malaria during pregnancy can cause maternal death,
severe maternal anemia, miscarriages, and pre-term and low-
birth-weight babies. Malaria in pregnancy is responsible for
about 100,000 babies and 10,000 women dying every year
but is preventable by simple, inexpensive interventions that
have been available for many years. The World Health
Organization recommends a three-pronged approach to the
prevention of malaria in pregnancy in areas with stable
malaria transmission in Africa—delivery of the antimalarial
drug sulfadoxine-pyrimethamine to pregnant women during
antenatal clinic visits (intermittent preventative treatment in
pregnancy; IPTp), the use of insecticide-treated bed nets
(ITNs) to protect pregnant women from the bites of infected
mosquitoes, and effective diagnosis and case management
of pregnant women with malarial illness.
Why Was This Study Done? Coverage with this preven-
tion strategy is currently very low. Recent survey data from
sub-Saharan African countries suggest that only about a
quarter of pregnant women receive two doses of IPTp and
only about a third use ITNs. To improve coverage, public
health experts need to understand why coverage is so low,
and they need to know the factors (determinants) that are
associated with the uptake of IPTp and ITNs. In this
systematic review and meta-analysis of qualitative, quantita-
tive, and mixed methods studies, the researchers explore the
factors that affect delivery, access, and use of IPTp and ITNs
among pregnant women in sub-Saharan Africa. A systematic
review uses predefined criteria to identify all the research on
a given topic. Meta-analysis is a statistical method for
combining the results of several studies. Qualitative studies
collect non-quantitative data such as reasons for not
accepting an intervention, whereas quantitative studies
collect numerical data such as the proportion of a population
accepting an intervention.
What Did the Researchers Do and Find? The research-
ers’ search of the Malaria in Pregnancy Library (a resource
maintained by the Malaria in Pregnancy Consortium) and the
Global Health Database identified 98 studies that provided
data on barriers to and determinants of IPTp and ITN uptake
and/or data on interventions designed to increase IPTp and
ITN uptake. The researchers explored these data using
content analysis (a research methodology that examines
words and phrases within texts) and narrative synthesis (a
method for summarizing results drawn from several quali-
tative studies). Key barriers to the provision and uptake of
IPTp and ITNs included unclear policy and guidance on IPTp,
general healthcare system issues such as drug shortages,
healthcare facility issues such as unavailability of water for
the provision of IPTp by directly observed therapy, poor
healthcare provider performance such as confusion about
the timing of IPTp doses, and the delayed antenatal care-
seeking practices of pregnant women. The researchers’
meta-analysis identified education, knowledge about malar-
ia, socio-economic status, number and timing of antenatal
clinic visits, and number of pregnancies as key determinants
of IPTp uptake, and employment status, education, knowl-
edge, age, and marital status as key determinants of
coverage of ITN use. So, for example, highly educated
women were more likely to receive IPTp or ITNs than poorly
educated women.
What Do These Findings Mean? These findings identify
key interacting barriers to access, delivery, and use of IPTp
and ITNs in sub-Saharan Africa and show that these barriers
are relatively consistent across countries. Moreover, they
suggest that there are fewer barriers to the delivery of ITNs
through antenatal clinics than to the delivery of IPTp.
Importantly, some of the barriers to IPTp uptake can be
resolved in the short term (for example, simplification of
country policies and guidance on IPTp might increase its
uptake), but barriers to uptake that are entrenched within
the overall healthcare system will only be resolved with
medium- to long-term strategies that aim to improve the
quality of antenatal services and to encourage antenatal
clinic use among women. Overall, this analysis provides a
checklist of factors that policy-makers involved in national
malaria programs may be able to use to help them decide
which interventions to prioritize. However, the researchers
warn, multi-country studies are nevertheless urgently need-
ed to evaluate targeted or multifaceted interventions
designed to increase delivery and uptake of IPTp and ITNs,
to reduce the adverse consequences of malaria in pregnan-
cy.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001488.
N Information is available from the World Health Organiza-
tion on malaria (in several languages) and on IPTp; the
World Malaria Report 2012 provides details of the current
global malaria situation
N The US Centers for Disease Control and Prevention also
provides information on malaria and on IPTp; a personal
story about malaria in pregnancy is available
N Information is available from the Roll Back Malaria
Partnership on all aspects of global malaria control,
including information on malaria in pregnancy
N The Malaria in Pregnancy Consortium is undertaking
research into the prevention and treatment of malaria in
pregnancy
N MedlinePlus provides links to additional information on
malaria (in English and Spanish)
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